9 Follicular Lymphoma Clinical Trials in Philadelphia, PA (2026)

Q: How do I join a clinical trial in Philadelphia?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Philadelphia research site will contact you.

Recruiting Follicular Lymphoma Studies in Philadelphia

NCT05108818Recruiting

Characterization of Humoral and Cellular Immune Responses Elicited by Influenza Vaccination in Healthy Adults

Cellular and humoral immune responses before and after seasonal influenza vaccination will be assessed. Each year, up to 100 participants will be enrolled. To study age-specific differences in immune ...

Philadelphia, PAPHASE4700 participantsUniversity of Pennsylvania

View Study Details

NCT07091630Recruiting

A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP

The main purpose of this study is to demonstrate the efficacy and safety of empasiprubart in adults with CIDP. The study consists of a part A where participants will either receive empasiprubart or pl...

Philadelphia, PAPHASE3160 participantsargenx

View Study Details

NCT04844606Recruiting

A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

The main purpose of this study is to evaluate the long-term efficacy of mirikizumab in pediatric participants with ulcerative colitis (UC) or Crohn's disease (CD). The study will last about 172 weeks ...

Philadelphia, PAPHASE3150 participantsEli Lilly and Company

View Study Details

NCT03346772Recruiting

Study of Immune Responses to Influenza Vaccination

Better understanding of the immune responses to influenza vaccination is needed in order to understand situations of poor vaccine response. Adults will receive influenza vaccination and then have peri...

Philadelphia, PAPHASE475 participantsUniversity of Pennsylvania

View Study Details

NCT06807840Recruiting

Flu Infection at UPHS

Cellular and humoral immune responses in individuals with active influenza infection will be assessed. Each year, up to 50 participants will be enrolled. The investigators hypothesize that influenza i...

Philadelphia, PA50 participantsUniversity of Pennsylvania

View Study Details

NCT07431606Recruiting

Duloxetine in Inflammatory Bowel Diseases

This open-label, prospective, single-arm pilot study investigates the use of duloxetine, a central neuromodulator, for improving psychological distress and functional impairment in adults with inflamm...

Philadelphia, PAPHASE232 participantsUniversity of Pennsylvania

View Study Details

NCT06222580Recruiting

SNDX-5613 and Gilteritinib for the Treatment of Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia and Concurrent MLL-Rearrangement or NPM1 Mutation

This phase I trial tests the safety, side effects, and best dose of SNDX-5613 and gilteritinib for treating patients with acute myeloid leukemia that has come back after a period of improvement (relap...

Philadelphia, PAPHASE130 participantsUma Borate

View Study Details

NCT04929236Recruiting

Study to Evaluate Safety and Efficacy of Different PANZYGA Dose Regimens in Pediatric Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Patients

Safety and Efficacy of Different PANZYGA Dose Regimens in Pediatric Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Patients...

Philadelphia, PAPHASE330 participantsOctapharma

View Study Details

NCT07343934Recruiting

huCART19-IL18-eDHFR Cells in Relapsed/Refractory Follicular Lymphoma

This is a phase 1, open-label study to evaluate the feasibility, safety and preliminary efficacy of huCART19-IL18-eDHFR cells administered in patients with relapsed or refractory follicular lymphoma. ...

Philadelphia, PAPHASE16 participantsUniversity of Pennsylvania

View Study Details

About Follicular Lymphoma Clinical Trials in Philadelphia

Follicular lymphoma is the second most common type of non-Hodgkin lymphoma and is typically a slow-growing (indolent) cancer. It develops from B-cells in the lymph nodes. Treatment ranges from watchful waiting to immunotherapy, chemotherapy, and targeted agents.

There are currently 9 follicular lymphoma clinical trials recruiting participants in Philadelphia, PA. These studies are seeking a combined 1,233 participants. Research is being sponsored by University of Pennsylvania, argenx, Eli Lilly and Company and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Follicular Lymphoma Clinical Trials in Philadelphia — FAQ

Are there follicular lymphoma clinical trials in Philadelphia?

Yes, there are 9 follicular lymphoma clinical trials currently recruiting in Philadelphia, PA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Philadelphia?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Philadelphia research site will contact you about next steps.

Are clinical trials in Philadelphia free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Philadelphia studies also compensate for your time and travel.

What follicular lymphoma treatments are being tested?

The 9 active trials in Philadelphia are testing new therapies including novel drugs, biologics, and treatment approaches for follicular lymphoma.

Data updated July 19, 2026 from ClinicalTrials.gov